Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
J Immunother Cancer
; 11(10)2023 10.
Article
in En
| MEDLINE
| ID: mdl-37802604
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphocytes, Tumor-Infiltrating
/
Melanoma
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos